ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,291Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 944

$506K Total Retail Price of All Prescriptions

Rank: 209 out of 944

323 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 323 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 4,961 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 290 229 1 6
HYDROCODONE-ACETAMINOPHEN 251 152 S3 2 10
SIMVASTATIN 218 187 3 1
LEVOTHYROXINE SODIUM 191 116 4 2
LISINOPRIL 183 143 5 3
ZOLPIDEM TARTRATE 172 112 6 25
OMEPRAZOLE 165 114 7 4
AMLODIPINE BESYLATE 148 117 8 5
POTASSIUM CHLORIDE 144 109 9 15
OXYCODONE HCL 134 41 S2 10 50
METOPROLOL SUCCINATE 123 87 11 14
CLOPIDOGREL 122 78 12 36
METFORMIN HCL 122 93 12 12
WARFARIN SODIUM 96 86 14 7
PLAVIX 87 58 15 55
CARVEDILOL 81 76 16 30
NEXIUM 79 56 17 53
DIOVAN 77 47 18 38
FLUOXETINE HCL 76 33 19 48
DIOVAN HCT 73 50 20 108
HYDROCHLOROTHIAZIDE 73 61 20 9
PHENYTOIN SODIUM EXTENDED 72 64 22 168
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 54 23 29
NAPROXEN 69 54 24 113
ACETAMINOPHEN-CODEINE 67 26 S3 25 95
ATORVASTATIN CALCIUM 67 26 25 13
PRAVASTATIN SODIUM 66 52 27 17
DONEPEZIL HCL 65 53 28 24
SERTRALINE HCL 65 57 28 23
ATENOLOL 64 57 30 11
INSULIN SYRINGE 62 48 31 121
TAMSULOSIN HCL 62 53 31 27
GABAPENTIN 57 29 33 18
LANTUS 57 47 33 46
AMOXICILLIN 55 26 35 171
KLOR-CON 10 55 21 35 115
PROAIR HFA 53 31 37 56
OXYCODONE HCL-ACETAMINOPHEN 52 0 S2 38 127
CYMBALTA 51 24 39 75
ARMOUR THYROID 50 15 R 40 285
CLONIDINE HCL 50 39 40 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.